AU7404494A - Methods and compositions for preventing immune rejection of solid organ grafts - Google Patents

Methods and compositions for preventing immune rejection of solid organ grafts

Info

Publication number
AU7404494A
AU7404494A AU74044/94A AU7404494A AU7404494A AU 7404494 A AU7404494 A AU 7404494A AU 74044/94 A AU74044/94 A AU 74044/94A AU 7404494 A AU7404494 A AU 7404494A AU 7404494 A AU7404494 A AU 7404494A
Authority
AU
Australia
Prior art keywords
compositions
methods
solid organ
immune rejection
preventing immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74044/94A
Inventor
Ronald J Berenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CellPro Inc
Original Assignee
CellPro Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CellPro Inc filed Critical CellPro Inc
Publication of AU7404494A publication Critical patent/AU7404494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
AU74044/94A 1993-07-21 1994-07-21 Methods and compositions for preventing immune rejection of solid organ grafts Abandoned AU7404494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9616693A 1993-07-21 1993-07-21
US096166 1993-07-21
PCT/US1994/008378 WO1995003062A1 (en) 1993-07-21 1994-07-21 Methods and compositions for preventing immune rejection of solid organ grafts

Publications (1)

Publication Number Publication Date
AU7404494A true AU7404494A (en) 1995-02-20

Family

ID=22255984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74044/94A Abandoned AU7404494A (en) 1993-07-21 1994-07-21 Methods and compositions for preventing immune rejection of solid organ grafts

Country Status (2)

Country Link
AU (1) AU7404494A (en)
WO (1) WO1995003062A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4236296A (en) * 1994-11-10 1996-06-06 Fred Hutchinson Cancer Research Center Intrathymic stem cell implantation
DE69637842D1 (en) * 1995-10-26 2009-04-02 Paul P Latta Induction of immunological tolerance
US6428782B1 (en) 1997-05-23 2002-08-06 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
DE69816812T2 (en) * 1997-05-23 2004-04-22 Hadasit Medical Research Services And Development Ltd. NON MYELOABLATIVE THERAPY FOR TOLERANCE INDUCTION
US6447767B1 (en) 1997-05-23 2002-09-10 Hadasit Medical Research Services And Development Ltd. Non-myeloablative tolerogenic treatment
JP2001523645A (en) * 1997-11-14 2001-11-27 ザ・ゼネラル・ホスピタル・コーポレイション Treatment of hematological disorders
US8609412B2 (en) 1999-08-05 2013-12-17 Regents Of The University Of Minnesota Mapc generation of lung tissue
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
US8252280B1 (en) 1999-08-05 2012-08-28 Regents Of The University Of Minnesota MAPC generation of muscle
EP2348104A1 (en) * 1999-08-05 2011-07-27 Mcl Llc Multipotent adult stem cells and methods for isolation
US10638734B2 (en) 2004-01-05 2020-05-05 Abt Holding Company Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
EP1367899A4 (en) * 2001-02-14 2004-07-28 Leo T Furcht Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2005003320A2 (en) 2003-07-02 2005-01-13 Regents Of The University Of Minnesota Neuronal differentiation of stem cells
US9005964B2 (en) 2006-11-24 2015-04-14 Regents Of The University Of Minnesota Endodermal progenitor cells
BR112018011327A2 (en) 2015-12-04 2018-12-04 Hutchinson Fred Cancer Res uses of expanded hematopoietic stem cell / progenitor populations
WO2019178106A1 (en) 2018-03-12 2019-09-19 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US10842821B2 (en) * 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2107897A1 (en) * 1991-04-09 1992-10-10 Ronald Hoffman System and process for supporting hematopoietic cells
ATE213505T1 (en) * 1991-11-05 2002-03-15 Univ Leland Stanford Junior SUPPRESSOR CELLS

Also Published As

Publication number Publication date
WO1995003062A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
AU7404494A (en) Methods and compositions for preventing immune rejection of solid organ grafts
AU6391896A (en) Nutritional and/or dietary composition and method of using the same
AU5214198A (en) Myocardial grafts and cellular compositions useful for same
AU5793396A (en) Human interferon tau compositions and methods of use
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
AU659183B2 (en) Surfactant composition and method of making the same
AU5404094A (en) Method for controlling o-desulfation of heparin and compositions produced thereby
AU7429291A (en) Combination of formate esters and pepper-like constituents as an orally-consumable chloroform substitute
AU4028995A (en) Antitumor compositions and methods of treatment
AU7780391A (en) Low level blasting composition and method of blasting same
AU6959694A (en) Antineoplastic compositions and methods of use
AU8955691A (en) Structural member and method of manufacture
AU8044491A (en) Antitumor compositions and methods of treatment
AU7782591A (en) Decorative tray or tray cover and method of forming
AU1448092A (en) Splitter and method of forming it
GB9407640D0 (en) Coating compositions and method of formimg
EP0673385A4 (en) Mammalian gap-43 compositions and methods of use.
AU7997491A (en) Extended-release plaque preventing and dissolving compositions and their method of use
AU1753892A (en) Mammalian gap-43 compositions and methods of use
AU8192691A (en) Method of treatment and compositions therefore
AU651992B2 (en) Polyethylene terephthalate compositions and methods of using thereof
AU3730497A (en) Compositions and articles of manufacture
AU4468093A (en) Composition and methods for the generation of bone